News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Ranbaxy Laboratories: FDA Issues Will Take Long Time to Resolve
November 9, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW DELHI -- Ranbaxy Laboratories Ltd. will take "a long time" to resolve issues with the U.S. Food and Drug Administration, Chief Executive Atul Sobti said Monday.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Asia
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Government
100+ CEOs, Biopharma Leaders Sound Alarm on ‘Catastrophic’ Health Cuts
June 30, 2025
·
2 min read
·
Tristan Manalac
Legal
Supreme Court Leaves PrEP Drug Coverage Decisions to RFK’s Task Force
June 27, 2025
·
2 min read
·
Annalee Armstrong
Vaccines
ACIP Skips Votes on COVID and Moderna’s mRESVIA but Scrutinzes mRNA Vaccine Safety
June 27, 2025
·
2 min read
·
Jef Akst
Collaboration
Alphabet Subsidiary Calico Colors In Up To $570M+ Aging Deal With China’s Mabwell
June 27, 2025
·
2 min read
·
Tristan Manalac
